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The objective of this study was to evaluate the effect of a PGF2a-analogue (PGF) on ovulation
andpregnancy ratesafter timedartiﬁcial insemination(TAI) incattle. Inexperiment1, crossbred
dual-purpose heifers, in a crossover design (3  3), were given an intravaginal progesterone-
releasing insert (controlled internal drug release [CIDR]) plus 1 mg estradiol benzoate (EB)
intramuscularly (im)and250mgof aPGF-analogue imonDay0. TheCIDR insertswere removed
5 days after follicular wave emergence, and the heifers were randomly divided into three
treatment groups to receive the following treatments: (1) 1mgof EB im (EB group, n¼ 13); (2)
500 mg of PGF im (PG group, n ¼ 13); or (3) saline (control group, n ¼ 13), 24 hours after CIDR
removal. Ovulation occurred earlier in EB (69.81  3.23 hours) and PG groups (73.09  3.23
hours) comparedwithcontrol (83.074.6hours;P¼0.01) afterCIDRremoval. Inexperiment2,
pubertal beef heifers (n¼ 444), 12 to 14 months of age were used. On Day 0, the heifers were
givenaCIDR insert plus 2mgEB im.OnDay9, theCIDRwas removedand theheiferswere given
500 mg of PGF im. Heiferswere randomly assigned into one of three treatment groups: (1) 1mg
of EB (EB group; n ¼ 145); (2) 500 mg of PGF (PG group; n ¼ 149), both 24 hours after CIDR
removal; or (3) 600 mg of estradiol cypionate (ECP group; n ¼ 150) at CIDR removal. Timed
artiﬁcial insemination occurred 48 hours after CIDR removal in the ECP group and 54 hours in
thePGandEBgroups. Thepercentageofheifersovulatingwashigher in thePGgroup compared
with the other groups (P ¼ 0.08). However, the pregnancy rates did not differ among groups
(47.6%, 45%, and 46.6%, for EB, PG, and ECP, respectively; P¼ 0.9). In experiment 3, 224 lactating
beef cows, 40 to 50 days postpartum with 2.5 to 3.5 of body condition score were treated
similarly as described in experiment 2, except for the ECP group, which was excluded. The
treatmentswere as follows: 1mgEB (EB group; n¼ 117) or 500 mg PGF (PG group; n¼ 107), 24
hours after CIDR removal. The calveswere temporarily separated from their dams fromDays 9
to11.Nodifferencewasdetectedonthepregnancy ratebetweentheEBandPGgroups (58.1%vs.
47.6%, respectively; P¼ 0.11). Taken together, the combined results suggested that PGF2a could
be successfully used to induce and synchronize ovulation in cattle undergoing TAI, with similar
pregnancy rates when compared with other ovulatory stimuli (ECP and EB).
 2014 Elsevier Inc. All rights reserved.x: þ55 69 3222 0409.
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Recently, considerable research efforts have focused on
developing technologies to induce synchronized ovulation
for timed artiﬁcial insemination (TAI) in beef [1–3] and dairy
cattle [4–6]. Treatments developed to control both luteal and
follicular function have permitted the exciting possibility of
controlling and synchronizing the time of ovulation and
artiﬁcial insemination without the need for estrus detection
[7]. Consistent TAI protocols have been extensively used by
South American beef and dairy industries, and the usual
protocol basically consists of an intravaginal progesterone
insert, estradiol benzoate (EB) to induce follicular wave
emergence, PGF2a analogues (PGFs) to induce luteolysis,
and an ovulatory stimulus of either an ester of estradiol
(benzoate or cypionate) or a GnRH analogue. This standard
protocol and its modiﬁcations provided satisfactory fertility
in commercial Brazilian herds, independent of breed (Bos
indicus, Bos taurus, or crossbreds).
In cattle, hormonal-based estrus synchronization pro-
tocols use PGF to regress a CL that might be functional by the
end of the protocol. It is known that prostaglandin is a bio-
logically potent substance with multiple applications in the
control of reproduction [8]. In cattle, the most common uses
are because of its luteolytic properties, which are useful for
estrous synchronization, regression of persistent CL, and
induction of abortion or parturition [9]. Although PGF and its
analogues are primarily used as luteolysins, they have also
been reported to have an effect on ovulation, embryo im-
plantation, pregnancy maintenance, and postpartum physi-
ology [8]. Moreover, PGF, which is primarily used for
synchronization of estrus alone or in association with pro-
gestins, estrogens, andGnRH, has also been reported to act as
an ovulatory stimulus in prepubertal heifers [10,11]. Prosta-
glandin F2a analogue increases pituitary responsiveness to
GnRH, thereby enhancing the release of LH [12] in a process
that results in ovulation. In our previous study, PGF treat-
ment induced ﬁrst ovulation in prepubertal heifers, inde-
pendent of whether heifers were pretreatedwith exogenous
progesterone [11]; however, its effectiveness as an ovulatory
inducer in TAI programs has not yet been studied.
On the basis of these considerations, the objectives of
this study were: 1) to evaluate whether exogenous
administration of PGF induces synchronized ovulations;
and 2) to study the efﬁcacy of PGF as an ovulatory stimulus
for TAI in cattle. We tested the hypotheses that exogenous
PGF 1) induces ovulation in a synchronized manner, and 2)
when used as an ovulatory stimulus, provides an efﬁciency
similar to esters of estradiol, which are usually used in TAI
programs in cattle.
2. Materials and methods
The Committee for Ethics in Animal Experimentation
from the Universidade Federal de Santa Maria approved all
of the procedures performed in these experiments.
2.1. Experiment 1
The experimental design is shown (Fig. 1A). This study
was performed at the experimental research farm ofEmbrapa Rondônia (Brazilian Agricultural Research Cor-
poration, Rondônia, Brazil; 084801200 S, 635005600 W).
Thirteen dual-purpose crossbred pubertal heifers (Gyr 
Holstein), 14 to 18 months and 290 to 360 kg body weight
were used. The heifers were kept in an outdoor grazing
system (Brachiaria brizantha pasture) with ad libitum
access to mineral salt and water.
All heifers were treated with an intravaginal
progesterone-releasing insert (1.9 g, controlled internal
drug release [CIDR], Pﬁzer Animal Health, São Paulo, Brazil)
plus 1 mg estradiol benzoate (EB; Bioestrogen, Biogénesis-
Bagó, Curitiba, Brazil) intramuscularly (im), and 250 mg im
of a PGF analogue, D-cloprostenol (Croniben, Biogénesis-
Bagó, Curitiba, Brazil) on Day 0. The CIDR inserts were
removed 5 days after follicular wave emergence (i.e.,
approximately 9 days after CIDR insertion) and all heifers
received an additional 250 mg im dose of D-cloprostenol at
this time point. Twenty-four hours after CIDR removal, the
heifers were randomly divided into three treatment
groups: 1) 1 mg EB (EB group, n¼ 13) im; 2) 500 mg PGF (PG
group, n ¼ 13) im; and 3) saline (control group, n ¼ 13) im.
The experiment was performed in a crossover design (3 
3) in which all heifers participated in all treatments groups
(e.g., 13 heifers per group). The interval between replicates
was 1 month.
2.2. Experiment 2
This experiment was performed at a commercial farm
located in the southern region of Brazil (322004600 S and
523203900 W). Pubertal crossbred Aberdeen Angus heifers
(n ¼ 444), 12 to 14 months and 313  25 kg body weight
were enrolled in this experiment.
The experimental design is shown (Fig. 1B). On Day 0,
the heifers were treated with CIDR and 2 mg EB (Gonadiol;
MSD Saúde Animal, São Paulo, Brazil) im. On Day 9, the
CIDRs were removed and the heifers received a 500 mg im
injection of a PGF analogue (sodium cloprostenol, Sincro-
sin; Vallée, Montes Claros, Minas Gerais, Brazil); and were
then randomly assigned into one of the following three
treatments: (1) 1 mg EB (EB group, n ¼ 145); (2) 500 mg
sodium cloprostenol (PG group, n ¼ 149) im; both groups
treated at 24 hours after CIDR removal (Day 10); and (3)
600 mg estradiol cypionate (ECP group, n ¼ 150; ECP;
Hertape Calier Saúde Animal, Juatuba, Minas Gerais, Brazil)
im at the same moment of CIDR removal (Day 9; Fig. 1B).
Timed artiﬁcial inseminations were performed 48  2
hours after CIDR removal in the ECP group and 54 2 hours
after CIDR removal in PG and EB groups. Two inseminators
performed all inseminations and semen straws from four
bulls of proven fertility were used for TAI.
2.3. Experiment 3
Experiment 3 was performed on the same commercial
farm as experiment 2 (Fig. 1C). Multiparous suckling
crossbred Aberdeen Angus cows, 40 to 50 days postpartum
with a body condition score (BCS) ranging from 2.5 to 3.5
(from 1 ¼ emaciated to 5 ¼ obese) were enrolled in this
experiment. Of the 341 cows initially available for the
experiment, 224 (65.7%) cows were considered suitable, on
Fig. 1. Experimental design for (A) heifers in experiment 1, (B) heifers in experiment 2, and (C) suckled cows in experiment 3. CIDR, controlled internal drug
release; D*, Day 5 of the follicular wave; D**, Day 6 of the follicular wave; EB, estradiol benzoate; ECP, estradiol cypionate; PGF, prostaglandin; TAI, timed artiﬁcial
insemination.
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detected using ultrasound examinations. All animals were
maintained on a pasture and with ad libitum access to
mineral salt and water.
The cows were treated and randomly allocated into
treatment groups, similar to the heifers in experiment 2,
except for the ECP group, which was absent this time: (1) EB
group (n ¼ 117) and (2) PG group (n ¼ 107). All calves were
temporarily separated from their dams from CIDR removal
(Day 9) to TAI (Day 11). During this 54 hour-interval, the
calves were kept in pens, whichwere out of the sight of their
dams, and had ad libitum access to water. The TAI was
performed 54  2 hours after CIDR removal (Fig. 1C). Two
inseminators performed all inseminations and semen straws
from two bulls of proven fertility were used for TAI.2.4. Ultrasonographic examinations
Before the initiation of the experiments, the cattle were
examined twice using transrectal ultrasonography, 7 to 11
days apart, to conﬁrm the presence of the CL and to eval-
uate the degree of uterine tonus, to ensure that all heifers
were pubertal and the cows had resumed postpartum
ovarian activity. Only cattle inwhich a CL was detected in at
least one of the examinations were included in this study.
In experiment 1, the heifers were scanned daily using
B-mode transrectal ultrasonography (Weld, equipped with
a 5 MHZ linear-array transducer; Beijing, China) to monitorovarian follicular development from Day 0 to Day 9, and
subsequently, twice daily until ovulation or in the absence
of ovulation, up to 5 days after CIDR removal. At each
scanning session, a sketch of each ovary was generated and
the diameter and location of follicles greater than or equal
to 3 mm in diameter were recorded according to methods
described elsewhere [13]. Ovulation was deﬁned as the
disappearance (from one scanning session to the next) of a
previously identiﬁed follicle greater than or equal to 8 mm
in diameter [14]. The day of wave emergence was deﬁned
retrospectively as the day when the dominant follicle was
ﬁrst detected at a diameter of 4 to 5mm [13]. In heifers that
ovulated, ultrasonographic examinations were performed
7 days later to determine the CL diameter.
In experiments 2 and 3, transrectal ultrasonography
(Honda HS-1500V, equipped with a 7.5 MHz linear-array
transducer; Toyohashi, Aichi, Japan) was performed in a
subset of 204 heifers (experiment 2) and 128 cows (exper-
iment 3) on Days 9 and 11 to determine the diameter of the
largest follicle, and also on Day 18 to determine the pres-
ence of the CL. Ultrasound examinationwas also performed
on Day 38 in all cattle to detect pregnancy.2.5. Statistical analysis
All statistical analyses were performed using the SAS 9.0
software (2006; SAS Institute Inc., Cary, NC, USA). In
experiment 1, single-point outcome variables (e.g., time of
Fig. 2. Comparison of the pattern of dominant follicle growth in heifers
treated with EB group, PG group, and nontreated controls. Exogenous EB and
PG were given on Day 6 of the follicular wave. EB, estradiol benzoate; PG,
prostaglandin F2a.
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and diameter of CL on Day 17) were analyzed using one-
way analysis of variance and the means were compared
among groups using Tukey’s post hoc test. Growth of the
dominant follicle from emergence to ovulation was
compared among groups using the MIXED procedure for
repeated measures to evaluate the main effects of treat-
ment and time (days) and their interactions [15]. In ex-
periments 2 and 3, in the initial analyses of the single-point
outcome variables (i.e., maximum diameter of the ovula-
tory follicle at CIDR removal and at TAI, interval to ovula-
tion, growth rate of the ovulatory follicle, diameter of the
CL), the statistical model included the effect of the bull,
inseminator, body weight, age, BCS, lactation number
(cows), and days postpartum (cows). The variables bull,
inseminator, body weight, age, lactation number, days
postpartum, and BCS had no signiﬁcant effect on the model
and were therefore excluded from the ﬁnal statistical
model. Thus, single-point outcome variables were analyzed
using one-way analysis of variance and means were
compared among groups using Tukey’s post hoc test. Pro-
portions with dichotomous outcomes (yes or no), such as
ovulation and pregnancy rates were analyzed using the
Chi-square test. Differences among groupswere considered
statistically signiﬁcant when the probability (P-value) was
less than or equal to 0.05.Fig. 3. Distribution and percentage of heifers ovulating after CIDR removal
in the EB group, PG group, and nontreated controls. EB, estradiol benzoate;
PG, prostaglandin F2a.3. Results
3.1. Experiment 1
Overall, progesterone inserts were removed 8.7  0.3
days after insertion (range, Day 7–Day 10). The ovarian
follicular growth proﬁle is shown in Figure 2. All heifers
ovulated within 5 days after CIDR removal. The interval
from CIDR removal to ovulation did not differ between the
EB and PG groups (69.82 3.23 hours vs. 73.13.23 hours,
respectively; P > 0.05). However, heifers in the control
group did ovulate later compared with the other two
groups (83.07  4.6 hours; P ¼ 0.01). Only one heifer
ovulated at 84 hours after CIDR removal in the PG group.
The distribution and percentage of heifers ovulating after
CIDR removal is shown in Figure 3.The diameter of the ovulatory follicle (P ¼ 0.36) and the
CL (P ¼ 0.46) did not differ among groups. Considering all
groups, the heifers ovulated a follicle with 14.8 1.9 mm in
diameter and formed a Day-7 CL of 22.9  2.9 mm in
diameter.
3.2. Experiment 2
The ovarian responses, ovulation and pregnancy rates in
heifers are summarized in Table 1. The percentage of heifers
ovulating tended to be higher in the PG group compared
with the EB and ECP groups (P ¼ 0.08). There was no dif-
ference in the pregnancy rates among groups (P ¼ 0.9). The
diameter of the dominant follicle on Day 9 was also not
different among groups (P ¼ 0.18). Nevertheless, heifers
treated with PGF had the largest dominant follicle at TAI;
conversely, heifers treated with ECP had the smallest
dominant follicles at TAI (P < 0.01).
3.3. Experiment 3
The ovarian responses, ovulation and pregnancy rates in
cows are summarized in Table 1. There was no difference in
the diameter of the dominant follicle at TAI, ovulation and
pregnancy rates among groups (P > 0.05). However,
dominant follicle on Day 9 tended to be greater in cows
treated with EB compared with cows treated with PGF (P ¼
0.07).
4. Discussion
The results of this study supported the initial hypothesis
that treatment with PGF would induce ovulations in a
synchronized manner. Moreover, we demonstrated that
exogenous PGF could be successfully used as an ovulatory
stimulus for TAI in heifers and cows. Although previous
studies have demonstrated the ability of PGF to induce
ovulation in prepubertal heifers [10,11], to the best of our
knowledge, this is the ﬁrst report to determine that PGF per
se can be used as an ovulatory stimulus for TAI. Most
importantly, this study demonstrated that if used as an
Table 1
Percentages of heifers (experiment 2) and cows (experiment 3) that ovulated and became pregnant, and themean (standard error of themean) diameter of
the dominant follicle on Days 9 and 11 in cattle treated with EB group, PG group, or ECP group as ovulatory stimuli.
Characteristics Heifers (experiment 2) Cows (experiment 3)
PG EB ECP P-value PG EB P-value
Ovulation rate 95.6% (66/69) 85.1% (57/67) 85.3% (58/68) 0.08 85.4% (53/62) 92.4% (61/66) 0.20
Pregnancy rate 45% (67/149) 47.6% (69/145) 46.6% (70/150) 0.9 47.6% (51/107) 58.1% (68/117) 0.11
Dominant follicle diameter (mm) on Day 9 10.2  0.2 12.1  1.6 9.9  0.2 0.18 10.7  0.2 11.2  0.23 0.07
Dominant follicle diameter (mm) at TAI 13.1  0.3a 12.2  0.2b 11.5  0.2c <0.001 13.6  0.33 13.2  0.39 0.41
Abbreviations: EB, estradiol benzoate; ECP, estradiol cypionate; PG, prostaglandin F2a; TAI, timed artiﬁcial insemination.
abc Values without a common superscript differed between groups.
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and suckled cows similar to that achieved using estradiol-
based ovulation inducers.
Although PGF tended to increase the ovulation rate in
heifers, no differences in pregnancy rates were detected in
cattle when PGF, EB, or ECP were used in the TAI protocol.
Prostaglandin F2a–induced synchronized ovulations in
cattle, thus providing satisfactory fertility in heifers and
cows subjected to TAI (given an expected pregnancy rate of
w50%). This was a remarkable achievement, particularly
because the current results were similar to that reported by
previous studiesusing treatmentswithEBandECP to induce
ovulation in heifers [16–18] and postpartum cows [18–21],
which achieved pregnancy rates ranging from 34% to 70%.
One could speculate that the results of the present study
were potentially associated to an indirect effect of PGF (by
inducing luteolysis, progesterone decrease, and subsequent
LH surge) rather than a direct effect of PGF on the follicle to
induce ovulation. Nevertheless, it was clearly demonstrated
in experiment 1 that PGF-induced ovulations occurred in a
pattern similar to that of EB-induced and the cattle ovulated
approximately 10 hours earlier compared with controls.
Martinez, et al. [22] reported that when an ovulatory
inducer was not used in association with the CIDR-based
protocol, ovulation occurs up to 108 hours after CIDR
removal, an interval that is most likely detrimental to the
pregnancy rate. For optimal fertility to TAI, ovulations must
occur synchronously (within a few hours) in most of the
treated cattle, with the least number of failures. In experi-
ment 1, the interval from insert removal to ovulation (me-
dian¼ 72 hours) was highly synchronized in heifers treated
with either PGF or EB 24 hours after CIDR removal. Other
studies have demonstrated a similar interval from CIDR
removal to ovulation using EB (w74 hours) [14,23], and LH
(w74 hours) [24] as ovulatory stimuli in heifers. In contrast,
ECP apparently causes a delay in ovulation (w81 hours) [16]
when compared with EB and PGF in heifers. In another
study, in which heifers were not exogenously induced to
ovulate, ovulations occurred on average at 82 hours after
insert removal [22], with an interval similar to that of the
control group in the present study. With regard to fertility,
although there were numerically less ovulations in both EB
and ECP groups in experiment 2 in this study, the pregnancy
rates were not negatively affected by this ﬁnding.
In the present study, we included a third treatment
group in experiment 2 (ECP), which aimed to compare the
most commonly adopted TAI protocol used by the South
American beef industry [2] with EB and PGF. Pregnancyrates were similar among all ovulatory inducers in heifers.
In contrast, in experiment 3, PGF-treated suckled cows had,
albeit not statistically signiﬁcant, less pregnancies (w10%)
than EB-treated cows. Although PGF-treated cows pre-
sented satisfactory pregnancy rates (47.6%) considering
their stage of lactation (50 days postpartum), EB-treated
females presented a pregnancy rate above these expecta-
tions (w60%). Although the present experiment was not
designed to address the potential variations in the moment
of ovulation between the PGF- and EB-treated suckled
cows, previous studies have reported that suckled cows
treated with EB ovulated, on average, 70 hours after pro-
gesterone insert removal [20,21]. Our results on the time of
ovulation in EB-treated heifers (experiment 1) were
consistent with those of previous reports. Thus, further
studies are required to determine the moment of ovulation
in suckling cows treated with PGF. If ovulation is delayed in
PGF-treated lactating cows, but still occurs in a synchro-
nized fashion, an appropriated TAI schedule may further be
adjusted to a PGF-based protocol, and consequently, preg-
nancy rates may increase and reach percentages that are
similar to that of EB-based protocols.
In the present study, there was a difference in the time
of PGF injections, during progesterone treatment, among
experiments (1 vs. 2 and 3). Two injections of PGF, on Day
0 and at CIDR removal, were used in experiment 1 to
rapidly decrease progesterone concentrations, which
potentially improved the synchronization of ovulation.
However, experiments 2 and 3 were performed at com-
mercial beef operations and, because of the logistic of these
farms, the standard TAI protocol commonly used was
adopted in that commercial herd. For this reason, we
injected a full dose (500 mg) of PGF on Day 9 instead of
dividing it into two injections. The requirement to follow
the farm’s standard management protocols was also the
reason for the use of temporarily calf removal in post-
partum cows (experiment 3). Regardless of these small
differences between experiments, the groups (PGF vs. EB
vs. ECP) were compared within each experiment, in which
all cattle received the same treatment. Thus, we believe
that the small differences between experimental pro-
cedures because of management did not affect the value of
the responses regarding the use of PGF to induce ovulation
in TAI protocols reported here. Indeed, these variations
provided supporting evidence of PGF effects on ovulation
induction under different management regimens.
Differences in the diameter of the largest follicle before
TAI detected in experiment 2 may be attributed to the
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administration of esters of estradiol (EB and ECP) resulted
in ovulation because of the induction of a synchronous LH
surge [25]. Nevertheless, the PGF mechanism of action to
induce ovulation most likely allowed the growth of the
follicle for a longer period compared with EB. In experi-
ment 2, heifers treated with PGF exhibited dominant fol-
licles that grew approximately 3 mm from Days 9 to 11,
whereas it did not grow during the same period in those
heifers treatedwith EB. This lack of growth of the dominant
follicle in heifers induced to ovulate with EB was most
likely because of an earlier increase in LH secretion, which
interrupted follicular growth and initiated cascading events
that eventually resulted in ovulation. The results of the
present study and those of previous reports [10,11] suggest
that PGF promotes ovulation via distinct mechanisms other
than only the indirect effect of luteolysis induction.
Several studies have attempted to understand how PGF
acts on inducing ovulation [12,26–28]. Previous reports have
demonstrated an increased frequency of LH release occur-
ring 6 hours after treatment with a PGF analogue in anes-
trous cows [12]. In addition, it has been suggested that PGF2a
exerts a direct effect on the anterior pituitary [8], which in-
creases pituitary responsiveness to GnRH and thereby en-
hances the release of LH [12]. In bulls, a subcutaneous
injection of 20 mg of PGF2a increased concentrations of LH
[29]. However, the effect of PGF on LH secretion is contro-
versial. Although PGF caused ovulation in anestrous cows
[30] and ewes [31], it was only associated with LH release in
cows. In addition to the central effect (pituitary–gonadal
axis) previously described, PGF also appears to play a local
role in the ovary. Prostaglandin secreted by the preovulatory
follicle was closely linked to the ovulatory process [26].
Prostaglandins (PGE2 and PGF2a) are produced by the
granulosa cells [32,33], and act directly on the preovulatory
follicle. Considering this ﬁnding, ovulation induced by PGF
could have an effect on sensitizing GnRH receptors in the
pituitary [12] or by direct action on target cells of the pre-
ovulatory follicles. Prostaglandins are putative intraovarian
mediators of several periovulatory events related to the
ovulatory gonadotropin surge [26]. Moreover, prostaglan-
dins appear to play a critical role in follicle rupture.
Cyclooxygenase COX-2 (also known as prostaglandin endo-
peroxide synthase and prostaglandin G/H synthase), which
catalyzes the rate-limiting step in the production of prosta-
glandin [34], is present in the mammalian ovary. Although
the interval between the onset of the ovulatory gonado-
tropin surge and follicle rupture varies in rodents (14 hours),
cows (28–30 hours), and horses (36–48 hours), COX-2
expression on the granulosa cells and elevated PG concen-
trations occurs in each of these species approximately 10
hours before follicle rupture [35]. In addition, deletion of
COX-2 gene expression in knockout mice decreased the
number of ovulations sites per ovary [36]. Thus, these reports
provided strong evidences that PGF acts locally in the ovary
during periovulatory events. Moreover, PGF secretion in-
creases signiﬁcantly in the follicle as ovulation approaches;
thus, giving a pharmacologic dose of PGF might hasten
ovulation.
Apparently, every prostaglandin analogue has the po-
tential to induce ovulation in many species. Manycommercial PGF analogues have been described to be
associated to periovulatory events in cattle: alfaprostol
[29], dinoprost [9], and sodium cloprostenol [10,11]; buf-
faloes: cloprostenol [37,38]; and ewes: D-cloprostenol [31].
Accordingly, both PGF analogues used in the present study
were effective to induce ovulation: D-cloprostenol in
experiment 1 and sodium cloprostenol in experiments 2
and 3. However, further studies on the effect of each single
PGF analogue on ovulation are still necessary to properly
evaluate speciﬁc properties of each compound.
Overall, the present study provides important data on
the use of PGF as an ovulatory stimulus for TAI programs in
cattle. From a commercial perspective, the major signiﬁ-
cance of this study was the possibility of developing a new
method to induce ovulation in cattle. Interestingly, PGF has
no withdrawal period, whereas estradiol esters do have a
long withdrawal period or are even prohibited in several
countries. Depending on the formula and the pharmaceu-
tical laboratory, an ester of estradiol may have awithdrawal
period of up to 30 days for milk and meat. Furthermore,
since 2008, the use of estradiol-17b has been banned in
farm animals by the European community because it has
been deemed a complete carcinogen by the Committee on
Veterinary Measures Relating Science to Public Health.
Thus, we strongly believe that PGF has a great potential to
induce ovulation in TAI programs, and especially in substi-
tution for estradiol or be used in GnRH-based protocols.
Prostaglandins could enhance the response to GnRH or
replace it, thereby reducing the costs of TAI protocols,
particularly in countries where the use of estradiol is pro-
hibited [39,40]. Although the TAI protocols used in this study
did not completely remove estradiol from treatments, we
abolished the second estradiol injection without decreasing
ovulation rate, resulting in 9 fewer days in the withdrawal
period, whichwould be cost-effective for the farmer. Further
studies are required to investigate whether PGF could
replace GnRH as a less expensive alternative in ovsynch-type
protocols, or provide additional options for incorporating
PGF-based protocols to cattle reproductive management
programs. Our group is currently working on experiments
aimed to appropriately respond to these challenges, and new
hypotheses are being tested in an attempt to answer the
above mentioned research questions.
4.1. Conclusions
Prostaglandin F2a analogue can be successfully used to
induce ovulation in a synchronized fashion in heifers. In
addition, the effectiveness of PGF as an ovulatory stimulus
for TAI was conﬁrmed in both heifers and cows on the basis
of satisfactory ovulation and pregnancy rates.
Acknowledgments
This researchwas supported by grants from theMinistry
of Science and Technology (MCT, Brazil) and EMBRAPA
(Project MP2 n 02.12.01.021.00.00). Natália Ávila Castro
(NAC) was supported by a CAPES scholarship from the
Ministry of Education of Brazil. The authors thank the
USASK and “4 Irmãos Farm” for providing hormones and
animals, respectively. The authors also thank personnel
L.F.M. Pfeifer et al. / Theriogenology 81 (2014) 689–695 695from the Embryolab from Universidade Federal de Santa
Maria, and Rafael Krusser, from the Programa de Pós-
graduação em Zootecnia from Universidade Federal de
Pelotas for providing technical assistance.
References
[1] Meneghetti M, Sa Filho OG, Peres RF, Lamb GC, Vasconcelos JL.
Fixed-time artiﬁcial insemination with estradiol and progesterone
for Bos indicus cows I: basis for development of protocols. Ther-
iogenology 2009;72:179–89.
[2] Sa Filho OG, Meneghetti M, Peres RF, Lamb GC, Vasconcelos JL.
Fixed-time artiﬁcial insemination with estradiol and progesterone
for Bos indicus cows II: strategies and factors affecting fertility.
Theriogenology 2009;72:210–8.
[3] Bo GA, Cutaia L, Chesta P, Moreno D. The use of eCG to increase
pregnancy rates in postpartum beef cows following treatment with
progesterone vaginal devices and estradiol benzoate and ﬁxed-time
AI. Reprod Fertil Develop 2004;16:127.
[4] Pereira MH, Sanches CP, Guida TG, Rodrigues AD, Aragon FL,
Veras MB, et al. Timing of prostaglandin F2alpha treatment in an
estrogen-based protocol for timed artiﬁcial insemination or timed
embryo transfer in lactating dairy cows. J Dairy Sci 2013;96:2837–46.
[5] Santos JE, Bartolome JA, Cerri RL, Juchem SO, Hernandez O, Trigg T,
et al. Effect of a deslorelin implant in a timed artiﬁcial insemination
protocol on follicle development, luteal function, and reproductive
performance of lactating dairy cows. Theriogenology 2004;61:421–35.
[6] Rivera H, Lopez H, Fricke PM. Use of intravaginal progesterone-
releasing inserts in a synchronization protocol before timed AI
and for synchronizing return to estrus in Holstein heifers. J Dairy Sci
2005;88:957–68.
[7] Bo GA, Baruselli PS, Moreno D, Cutaia L, Caccia M, Tribulo R, et al.
The control of follicular wave development for self-appointed em-
bryo transfer programs in cattle. Theriogenology 2002;57:53–72.
[8] Weems CW, Weems YS, Randel RD. Prostaglandins and reproduc-
tion in female farm animals. Vet J 2006;171:206–28.
[9] Gabriel HG, Wallenhorst S, Dietrich E, Holtz W. The effect of pros-
taglandin F(2alpha) administration at the time of insemination on
the pregnancy rate of dairy cows. Anim Reprod Sci 2011;123:1–4.
[10] Pfeifer LFM, Siqueira LG, Mapletoft RJ, Kastelic JP, Adams GP,
Colazo MG, et al. Effects of exogenous progesterone and clopros-
tenol on ovarian follicular development and ﬁrst ovulation in pre-
pubertal heifers. Theriogenology 2009;72:1054–64.
[11] Leonardi CE, Pfeifer LF, Rubin MI, Singh J, Mapletoft RJ, Pessoa GA,
et al. Prostaglandin F2alpha promotes ovulation in prepubertal
heifers. Theriogenology 2012;78:1578–82.
[12] Randel RD, Lammoglia MA, Lewis AW, Neuendorff DA, Guthrie MJ.
Exogenous PGF(2)alpha enhanced GnRH-induced LH release in
postpartum cows. Theriogenology 1996;45:643–54.
[13] Ginther OJ, Knopf L, Kastelic JP. Temporal associations among
ovarian events in cattle during oestrous cycles with two and three
follicular waves. J Reprod Fertil 1989;87:223–30.
[14] Martinez MF, Kastelic JP, Bo GA, Caccia M, Mapletoft RJ. Effects of
oestradiol and some of its esters on gonadotrophin release and
ovarian follicular dynamics in CIDR-treated beef cattle. Anim
Reprod Sci 2005;86:37–52.
[15] Littell RC, Henry PR, Ammerman CB. Statistical analysis of repeated
measures data using SAS procedures. J Anim Sci 1998;76:1216–31.
[16] Colazo MG, Kastelic JP, Mapletoft RJ. Effects of estradiol cypionate
(ECP) on ovarian follicular dynamics, synchrony of ovulation, and
fertility in CIDR-based, ﬁxed-time AI programs in beef heifers.
Theriogenology 2003;60:855–65.
[17] Colazo MG, Kastelic JP, Martinez MF, Whittaker PR, Wilde R,
Ambrose JD, et al. Fertility following ﬁxed-time AI in CIDR-treated
beef heifers given GnRH or estradiol cypionate and fed diets sup-
plemented with ﬂax seed or sunﬂower seed. Theriogenology 2004;
61:1115–24.
[18] Martinez MF, Kastelic JP, Adams GP, Mapletoft RJ. The use of GnRH or
estradiol to facilitate ﬁxed-time insemination in an MGA-based syn-
chronization regimen in beef cattle. Anim Reprod Sci 2001;67:221–9.
[19] Baruselli PS, Reis EL, Marques MO, Nasser LF, Bo GA. The use of
hormonal treatments to improve reproductive performance ofanestrous beef cattle in tropical climates. Anim Reprod Sci 2004;82-
83:479–86.
[20] Sales JN, Carvalho JB, Crepaldi GA, Cipriano RS, Jacomini JO, Maio JR,
et al. Effects of two estradiol esters (benzoate and cypionate) on the
induction of synchronized ovulations in Bos indicus cows submitted
to a timed artiﬁcial insemination protocol. Theriogenology 2012;78:
510–6.
[21] Ayres H, Martins CM, Ferreira RM, Mello JE, Dominguez JH,
Souza AH, et al. Effect of timing of estradiol benzoate administration
upon synchronization of ovulation in suckling Nelore cows (Bos
indicus) treated with a progesterone-releasing intravaginal device.
Anim Reprod Sci 2008;109:77–87.
[22] Martinez MF, Adams GP, Kastelic JP, Bergfel DR, Mapletoft RJ. In-
duction of follicular wave emergence for estrus synchronization and
artiﬁcial insemination in heifers. Theriogenology 2000;54:757–69.
[23] Carvalho JB, Carvalho NA, Reis EL, Nichi M, Souza AH, Baruselli PS.
Effect of early luteolysis in progesterone-based timed AI protocols
in Bos indicus, Bos indicus  Bos taurus, and Bos taurus heifers.
Theriogenology 2008;69:167–75.
[24] Pfeifer LF, Mapletoft RJ, Kastelic JP, Small JA, Adams GP, Dionello NJ,
et al. Effects of low versus physiologic plasma progesterone con-
centrations on ovarian follicular development and fertility in beef
cattle. Theriogenology 2009;72:1237–50.
[25] Lammoglia MA, Short RE, Bellows SE, Bellows RA, MacNeil MD,
Hafs HD. Induced and synchronized estrus in cattle: dose titration of
estradiol benzoate in peripubertal heifers and postpartum cows
after treatment with an intravaginal progesterone-releasing insert
and prostaglandin F2alpha. J Anim Sci 1998;76:1662–70.
[26] Murdoch WJ, McCormick RJ. Mechanisms and physiological impli-
cations of leucocyte chemoattraction into periovulatory ovine fol-
licles. J Reprod Fertil 1993;97:375–80.
[27] Fortune JE, Willis EL, Bridges PJ, Yang CS. The periovulatory period
in cattle: progesterone, prostaglandins, oxytocin and ADAMTS
proteases. Anim Reprod 2009;6:60–71.
[28] Naor Z, Jabbour HN, Naidich M, Pawson AJ, Morgan K, Battersby S,
et al. Reciprocal cross talk between gonadotropin-releasing hor-
mone (GnRH) and prostaglandin receptors regulates GnRH receptor
expression and differential gonadotropin secretion. Mol Endocrinol
2007;21:524–37.
[29] Kiser TE, Hafs HD, Oxender WD. Increased blood LH and testos-
terone after administration of prostaglandin F2alpha in bulls.
Prostaglandins 1976;11:545–53.
[30] Cruz LC, do Valle ER, Kesler DJ. Effect of prostaglandin F2 alpha and
gonadotropin releasing hormone-induced luteinizing hormone re-
leases on ovulation and corpus luteum function of beef cows. Anim
Reprod Sci 1997;49:135–42.
[31] Davies KL, Bartlewski PM, Epp T, Duggavathi R, Barrett DM, Bagu ET,
et al. Does injection of prostaglandin F(2alpha) (PGF2alpha) cause
ovulation in anestrous Western White Face ewes? Theriogenology
2006;66:251–9.
[32] Bridges PJ, Fortune JE. Progesterone mediates gonadotrophin-
induced secretion of prostaglandins E and F2a (PGE, PGF) by
follicular cells from bovine preoculatory follicles [Abstract]. Biol
Reprod 2003;68(Suppl 1):47.
[33] Evans G, Dobias M, King GJ, Armstrong DT. Production of prosta-
glandins by porcine preovulatory follicular tissues and their roles in
intrafollicular function. Biol Reprod 1983;28:322–8.
[34] Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev
Pharmacol Toxicol 1998;38:97–120.
[35] Duffy DM, Stouffer RL. The ovulatory gonadotrophin surge stimu-
lates cyclooxygenase expression and prostaglandin production by
the monkey follicle. Mol Hum Reprod 2001;7:731–9.
[36] Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM,
et al. Multiple female reproductive failures in cyclooxygenase
2-deﬁcient mice. Cell 1997;91:197–208.
[37] Neglia G, Natale A, Esposito G, Salzillo F, Adinolﬁ L, Campanile G,
et al. Effect of prostaglandin F2alpha at the time of AI on proges-
terone levels and pregnancy rate in synchronized Italian Mediter-
ranean buffaloes. Theriogenology 2008;69:953–60.
[38] Neglia G, Vecchio D, Russo M, Di Palo R, Pacelli C, Comin A, et al.
Efﬁcacy of PGF(2alpha) on pre-ovulatory follicle and corpus luteum
blood ﬂow. Reprod Dom Anim 2012;47:26–31.
[39] 96/22/EC., C.D., Off J Eur Comm 1996; L:125: p. 3–9.
[40] 2002/657/EC, C.D., Off J Eur Comm 2002; L221: p. 8–36.
